EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Molecular Hybrids of Quinoline and Sulfonamide: Design, Synthesis and in Vitro Anticancer Studies

Padyala Panduranga, Parameshwar Makam, Naresh Kumar Katari iD, Rambabu Gundla, Sreekantha Babu Jonnalagadda, Bharat Kumar Tripuramallu

ChemistryOpen · 2025-03 · 14 (3)

DOI: 10.1002/open.202400334 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemistryOpen, online erschienen am 26.11.2024. Verfasst von Padyala Panduranga und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, VFSTR (Deemed to be University), Vadlamudi, Guntur, Andhra Pradesh, 522213, India. Hauptthemen laut MEDLINE: Quinolines, Antineoplastic Agents, Sulfonamides, Drug Design. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Molecular hybrids of diversely functionalized quinoline and sulfonamide have been designed. Multistep synthetic strategies have been used for the synthesis. The anti‐cancer properties have been evaluated against various cancer cell lines including HCT116, A549, U2OS, CCRF‐CEM, Jurkat, MOLT‐4, RAMOS, and K562. Non‐cancer cell lines MRC‐5 and BJ were also included for comparison. When examining the effects on A549, HCT116, and U2OS cells, all tested compounds exhibited limited potency with IC 50 values exceeding 50 μM, indicating weak activity against these cell lines. Against the ITK high cells Viz . are Jurkat, CCRF‐CEM and MOLT‐4, 9 e, 9 p and 9 j found to the maximum potent compounds with IC 50 values of 7.43±7.40 μM, 13.19±1.25 μM and 5.57±7.56 μM respectively. Similarly, in the BTK high cells screenings, 9 n and 9 e molecules with an IC 50 value of 2.76±0.79 μM and 5.47±1.71 μM against RAMOS and K562 respectively are highly potent. Interestingly, all the molecules have exhibited IC 50 value >50 μM against the non‐cancer cells (MRC‐5 and BJ), which indicates the promising non‐cytotoxic nature of the molecules.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

QuinolinesAntineoplastic AgentsSulfonamidesDrug DesignHumansDrug Screening Assays, AntitumorCell Line, TumorStructure-Activity RelationshipCell ProliferationMolecular Structure

Stichwörter der Autor:innen

Molecular hybridsQuinolineSulfonamideSynthesis and in vitro anticancer study

Substanzen

QuinolinesAntineoplastic AgentsSulfonamidesquinoline

Autor:innen und Institutionen

  • Department of Chemistry, VFSTR (Deemed to be University), Vadlamudi, Guntur, Andhra Pradesh, 522213, India.
  • Division of Research and Innovation, Department of Chemistry, Uttaranchal University,Arcadia Grant, P.O. Chandanwari, Premnagar, Dehradun Uttarakhand, 248007, India.
  • School of Chemistry & Physics, College of Agriculture, Engineering & Science, Westville Campus, University of KwaZulu-Natal, P Bag X 54001, Durban, 4000, South Africa.
  • Department of Chemistry, GITAM School of Science, GITAM Deemed to be University, Hyderabad, Telangana, 502329, India.

ORCID-Profile: Naresh Kumar Katari

Zitieren

APA

Panduranga, P., Makam, P., Kumar Katari, N., Gundla, R., Babu Jonnalagadda, S., & Kumar Tripuramallu, B. (2025). Molecular Hybrids of Quinoline and Sulfonamide: Design, Synthesis and in Vitro Anticancer Studies. ChemistryOpen, 14(3). https://doi.org/10.1002/open.202400334

Vancouver

Panduranga P, Makam P, Kumar Katari N, Gundla R, Babu Jonnalagadda S, Kumar Tripuramallu B. Molecular Hybrids of Quinoline and Sulfonamide: Design, Synthesis and in Vitro Anticancer Studies. ChemistryOpen. 2025;14(3). doi:10.1002/open.202400334

BibTeX
@article{Panduranga2025,
  author = {Panduranga, Padyala and Makam, Parameshwar and Kumar Katari, Naresh and Gundla, Rambabu and Babu Jonnalagadda, Sreekantha and Kumar Tripuramallu, Bharat},
  title = {Molecular Hybrids of Quinoline and Sulfonamide: Design, Synthesis and in Vitro Anticancer Studies},
  journal = {ChemistryOpen},
  year = {2025},
  volume = {14},
  number = {3},
  doi = {10.1002/open.202400334}
}
Kostenlos starten →